US Pharm. 2012;37(2):10.
Rochester, MN—Researchers at the Mayo Clinic have found that the use of statins in postmenopausal women is associated with an increased risk of developing type 2 diabetes. Women’s Health Initiative data through 2005 were analyzed, looking at 153,840 women without diabetes and an average age of 63 years. Statin use was assessed at enrollment and in year 3. The results indicated 10,242 new cases of diabetes, with statin use at baseline associated with an increased risk of the disease. Researchers concluded that “given the wide use of statins in the aging population, further studies among women, men, and diverse ethnicities will clarify DM [diabetes mellitus] risk and risk management to optimize therapy.”
To comment on this article, contact rdavidson@uspharmacist.com.
